Recently, an epidermal growth factor receptor (EGFR) targeted NIR fluorescent probe enabled a fluorescence lifetime imaging approach to enhance tumour contrast with a proven safety profile in humans, suggesting a strong potential for clinical applications in image-guided surgery, cancer diagnostics and staging [39]. Here, EGFR is linked to cancer.